Surveillance and Follow-up Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Surveillance and Follow-up. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Surveillance and Follow-up Indian Medical PG Question 1: Which of the following is not true about osteosarcoma?
- A. Seen in the metaphyseal region of the long bones
- B. Lung metastasis is common
- C. Secondary osteosarcoma is seen in older age groups
- D. Most commonly arises in the epiphyseal region (Correct Answer)
Surveillance and Follow-up Explanation: ***Most commonly arises in the epiphyseal region***
- This statement is **FALSE** - osteosarcoma most commonly arises in the **metaphyseal region** of long bones, particularly around the knee (distal femur, proximal tibia) and proximal humerus [1].
- The metaphysis is the region where bone growth is most active, which explains why osteosarcoma preferentially occurs there.
- The epiphysis (growth plate region) is **not** the typical location for osteosarcoma.
*Seen in the metaphyseal region of the long bones*
- This is **TRUE** - osteosarcoma characteristically arises in the **metaphyseal regions** of long bones, especially around the knee and proximal humerus where growth is most active [1].
*Lung metastasis is common*
- This is **TRUE** - the lungs are the most common site of distant metastasis in osteosarcoma, occurring in up to 80% of patients who develop metastatic disease [1].
- Pulmonary metastasis significantly impacts prognosis and treatment [1].
*Secondary osteosarcoma is seen in older age groups*
- This is **TRUE** - while primary osteosarcoma affects children and young adults (peak 10-20 years), **secondary osteosarcoma** occurs in older patients, typically arising in association with Paget's disease, prior radiation therapy, or bone infarcts [1].
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1200-1202.
Surveillance and Follow-up Indian Medical PG Question 2: Distant bone metastases can be best detected by which of the following imaging techniques?
- A. Bone scan (Correct Answer)
- B. CT
- C. Intravenous venogram
- D. PET scan
Surveillance and Follow-up Explanation: ***Bone scan***
- A **bone scan** is highly sensitive for detecting **osteoblastic activity**, which is characteristic of most bone metastases.
- It involves injecting a **radioactive tracer** (usually technetium-99m methylene diphosphonate) that accumulates in areas of increased bone turnover, making it excellent for surveying the entire skeletal system.
*PET scan*
- While a **PET scan** (Positron Emission Tomography) can detect bone metastases, especially with **FDG-PET**, it is generally more expensive and may not be as sensitive for purely **osteoblastic lesions** as a bone scan.
- Its primary role is often in assessing metabolic activity of the primary tumor and other distant soft tissue metastases.
*CT*
- **CT scans** (Computed Tomography) are excellent for assessing bone anatomy, cortical destruction, and soft tissue involvement, but they are generally less sensitive for detecting early or widespread **osseous metastatic disease** compared to a bone scan.
- CT provides detailed anatomical information but may miss early **marrow involvement** that alters bone metabolism.
*Intravenous venogram*
- An **intravenous venogram** is an imaging technique used to visualize veins, primarily for detecting **thrombosis** or venous insufficiency.
- It has no role in the detection of **bone metastases**, as it provides no information about bone structure or metabolic activity.
Surveillance and Follow-up Indian Medical PG Question 3: What is the average time interval between radiation exposure and genesis of post-radiation osteosarcoma?
- A. 16 yrs (Correct Answer)
- B. 4 yrs
- C. 8 yrs
- D. 2 yrs
Surveillance and Follow-up Explanation: ***16 yrs***
- The latency period for **radiation-induced osteosarcomas** is typically long, often exceeding a decade.
- Studies have shown the average interval between therapeutic radiation and the development of osteosarcoma to be around **10-20 years**, with 16 years being a well-supported average.
*4 yrs*
- A 4-year interval is generally too short for the development of a **secondary osteosarcoma** after radiation exposure.
- While other radiation-induced pathologies might manifest earlier, the transformation to osteosarcoma requires a sustained period of genetic damage and cellular changes.
*8 yrs*
- An 8-year latency period is still relatively short for most radiation-induced osteosarcomas to develop.
- While some cases might occur within this timeframe, the average and modal latency periods are typically longer, reflecting the multi-step process of **carcinogenesis**.
*2 yrs*
- A 2-year interval is exceptionally rare for the development of a **radiation-induced osteosarcoma**.
- This short period does not align with the known biological mechanisms and latency associated with radiation-induced bone malignancies.
Surveillance and Follow-up Indian Medical PG Question 4: What is the significance of a 2-year post-treatment surveillance period in paucibacillary leprosy?
- A. To monitor for treatment compliance during active therapy
- B. To assess the effectiveness of multibacillary leprosy treatment protocols
- C. To detect early signs of drug resistance in ongoing treatment
- D. To identify relapses, reactions, and neurological complications after treatment completion (Correct Answer)
Surveillance and Follow-up Explanation: ***To identify relapses, reactions, and neurological complications after treatment completion***
- The 2-year post-treatment surveillance period for **paucibacillary leprosy** is crucial for monitoring for **relapses** which can occur even after successful multidrug therapy (MDT).
- It also allows for the early detection and management of **leprosy reactions** (e.g., Type 1 reversal reactions) and **neurological complications** such as nerve damage, which can develop or progress after treatment completion.
*To monitor for treatment compliance during active therapy*
- Monitoring for **treatment compliance** occurs *during* the active 6-month MDT period for paucibacillary leprosy, not primarily in the 2-year post-treatment surveillance phase.
- While compliance is essential for successful treatment, the post-treatment period is focused on after-effects.
*To assess the effectiveness of multibacillary leprosy treatment protocols*
- This surveillance period is specifically for **paucibacillary leprosy**, which has a different treatment regimen and surveillance duration (6 months MDT followed by 2 years surveillance) compared to multibacillary leprosy (12 months MDT followed by 5 years surveillance).
- The effectiveness of multibacillary treatment protocols would be assessed over a longer period following completion of its own specific MDT.
*To detect early signs of drug resistance in ongoing treatment*
- Detection of **drug resistance** is typically assessed *during* treatment if a patient is not responding clinically or shows signs of worsening, or in cases of relapse where drug resistance might be suspected as the cause.
- While possible, the primary purpose of post-treatment surveillance is broader than just drug resistance; it encompasses all potential adverse long-term outcomes.
Surveillance and Follow-up Indian Medical PG Question 5: A 45 yrs male presented with an expansile lesion in the centre of femoral metaphysis. The lesion shows Endosteal scalloping and punctuate calcifications. Most likely diagnosis is:
- A. Fibrous Dysplasia
- B. Chondrosarcoma (Correct Answer)
- C. Simple bone cyst
- D. Osteosarcoma
Surveillance and Follow-up Explanation: ***Chondrosarcoma***
- An **expansile lesion** within the **femoral metaphysis** with **endosteal scalloping** and **punctate calcifications** is highly characteristic of a chondrosarcoma.
- The punctate/arc-and-ring calcifications are typical for cartilage matrix, which is the hallmark of chondrosarcoma, and the patient's age (45 years) fits the typical demographic.
*Fibrous Dysplasia*
- This condition presents as a **ground-glass matrix** on imaging, not punctate calcifications.
- While it can be expansile, it typically does not show prominent endosteal scalloping with cartilage calcifications.
*Simple bone cyst*
- Simple bone cysts are typically **lytic lesions** that do not show punctate calcifications or aggressive endosteal scalloping.
- They are often **fluid-filled** and common in children/adolescents, whereas this patient is 45 years old.
*Osteosarcoma*
- Osteosarcomas are characterized by **osteoid matrix formation** and often have a more aggressive appearance with a **sunburst or spiculated periosteal reaction** and bone formation, not punctate cartilage calcifications.
- While it can be expansile, the calcification pattern described points away from osteosarcoma.
Surveillance and Follow-up Indian Medical PG Question 6: Most common site of osteogenic sarcoma is:
- A. Tibia, lower end
- B. Femur, upper end
- C. Tibia, upper end
- D. Femur, lower end (Correct Answer)
Surveillance and Follow-up Explanation: ***Femur, lower end***
- The **distal femur** is the most common site for osteogenic sarcoma, accounting for approximately **40% of all cases** [1].
- This region, along with the **proximal tibia**, are the most frequent locations for this primary bone tumor [1].
*Tibia, lower end*
- While osteogenic sarcoma can occur in the **tibia**, the **proximal end** is more commonly affected than the distal end.
- The distal tibia is a less frequent site compared to the distal femur or proximal tibia.
*Femur, upper end*
- The **proximal femur** is a recognized site for osteogenic sarcoma, but it is less common than the **distal femur**.
- Tumors in the proximal femur account for a smaller percentage of overall osteosarcoma cases.
*Tibia, upper end*
- The **proximal tibia** is the **second most common site** for osteogenic sarcoma, frequently affected after the distal femur [1].
- However, the question asks for the *most* common site, which remains the distal femur.
Surveillance and Follow-up Indian Medical PG Question 7: In the treatment of osteosarcoma, all of the following chemotherapy agents are used EXCEPT:
- A. High dose methotrexate
- B. Cyclophosphamide
- C. Vincristine (Correct Answer)
- D. Doxorubicin
Surveillance and Follow-up Explanation: **Explanation:**
The standard of care for **Osteosarcoma** involves a multimodal approach consisting of neoadjuvant chemotherapy, wide local surgical excision (limb-salvage surgery), and adjuvant chemotherapy.
**Why Vincristine is the correct answer:**
Vincristine is a vinca alkaloid that inhibits microtubule formation. While it is a cornerstone in the treatment of **Ewing’s Sarcoma** (as part of the VAC/VAI regimen), it has no proven efficacy against Osteosarcoma. Therefore, it is not included in standard osteosarcoma protocols.
**Analysis of other options:**
* **High-dose Methotrexate (with Leucovorin rescue):** This is a primary agent used to inhibit dihydrofolate reductase, crucial for treating high-grade osteosarcoma.
* **Doxorubicin (Adriamycin):** An anthracycline that remains one of the most effective drugs for bone sarcomas.
* **Cyclophosphamide:** While not part of the primary "MAP" (Methotrexate, Adriamycin, Platinum) regimen, it is frequently used in **second-line or salvage therapy** for recurrent or refractory osteosarcoma.
**High-Yield NEET-PG Pearls:**
1. **Standard Regimen (MAP):** The most common chemotherapy combination for Osteosarcoma is **M**ethotrexate, **A**driamycin (Doxorubicin), and **P**latin (Cisplatin).
2. **Ewing’s Sarcoma Regimen:** Remember the mnemonic **VAC** (Vincristine, Adriamycin, Cyclophosphamide) or **VAI** (Ifosfamide instead of Cyclophosphamide).
3. **Prognostic Marker:** The most important prognostic factor in osteosarcoma is the **histologic response to neoadjuvant chemotherapy** (Huvos grade; >90% necrosis indicates a good prognosis).
4. **Radio-resistance:** Osteosarcoma is generally radio-resistant, making chemotherapy and surgery the mainstays of treatment.
Surveillance and Follow-up Indian Medical PG Question 8: Which of the following statements is true regarding hemangioma of the bone?
- A. Occurs commonly in skull bones.
- B. Requires observation as it is premalignant.
- C. Hamartomatous in origin. (Correct Answer)
- D. Forms 10-12% of bone tumors.
Surveillance and Follow-up Explanation: **Explanation:**
**Hemangioma of the bone** is a benign, slow-growing vascular lesion. The correct answer is **C** because these lesions are considered **hamartomatous** in origin—meaning they are a malformation of normal vascular tissue (capillary, cavernous, or venous) rather than a true neoplastic growth.
**Analysis of Options:**
* **Option A (Incorrect):** While hemangiomas can occur in the skull, the **vertebral column** (specifically the thoracic and lumbar spine) is the most common site, followed by the skull.
* **Option B (Incorrect):** Hemangiomas are strictly **benign** and have no documented malignant potential. Most are asymptomatic and require observation only because they are harmless, not because they are premalignant.
* **Option D (Incorrect):** They are relatively common incidental findings (found in ~10% of autopsies), but they account for only **0.7% to 1%** of all primary bone tumors, not 10-12%.
**High-Yield Clinical Pearls for NEET-PG:**
* **Radiological Signs:**
* **Vertebra:** Shows a characteristic **"Jail-bar"** or **"Corduroy cloth"** appearance due to the thickening of vertical trabeculae.
* **Skull:** Shows a classic **"Sunburst"** or **"Spoke-wheel"** pattern of trabeculation.
* **Management:** Most are asymptomatic and require no treatment. If symptomatic (e.g., spinal cord compression), options include radiotherapy, embolization, or surgical decompression.
* **Polka-dot Sign:** On CT scans of the vertebrae, the cross-section of thickened vertical trabeculae appears as multiple small dots.
Surveillance and Follow-up Indian Medical PG Question 9: Osteosarcoma commonly affects which part of a long bone?
- A. Metaphysis (Correct Answer)
- B. Diaphysis
- C. Epiphysis
- D. None of the above
Surveillance and Follow-up Explanation: **Explanation:**
**1. Why Metaphysis is Correct:**
Osteosarcoma is a primary malignant bone tumor characterized by the production of osteoid (immature bone) by malignant cells. It most commonly occurs in the **metaphysis** of long bones (especially the distal femur, proximal tibia, and proximal humerus). The underlying medical reason is that the metaphysis is the site of **maximum metabolic activity and rapid cell turnover** during the adolescent growth spurt. Since Osteosarcoma is a tumor of primitive mesenchymal cells, it predilects areas where bone remodeling and growth are most intense.
**2. Why Other Options are Incorrect:**
* **Diaphysis (B):** This is the shaft of the bone. While less common for Osteosarcoma, the diaphysis is the classic site for **Ewing’s Sarcoma**, Adamantinoma, and Osteoid Osteoma.
* **Epiphysis (C):** This is the end of the bone. Tumors in this location are rare. The two "classic" epiphyseal tumors are **Giant Cell Tumor (GCT)** (after physeal closure) and **Chondroblastoma** (before physeal closure).
**3. Clinical Pearls for NEET-PG:**
* **Age Group:** Most common in the 2nd decade of life (10–20 years).
* **Radiological Signs:** Look for the **"Sunray appearance"** or **"Sunburst appearance"** (due to spiculated periosteal reaction) and **Codman’s Triangle** (due to the elevation of the periosteum).
* **Laboratory:** Serum **Alkaline Phosphatase (ALP)** is often elevated and serves as a marker for prognosis and treatment response.
* **Genetics:** Strongly associated with mutations in the **Rb gene** (Retinoblastoma) and **TP53 gene** (Li-Fraumeni syndrome).
* **Spread:** Hematogenous spread to the **lungs** is the most common site of metastasis.
Surveillance and Follow-up Indian Medical PG Question 10: A 50-year-old lady presented with a 3-month history of pain in the lower third of the right thigh. There was no local swelling; tenderness was present on deep pressure. Plain X-rays showed an ill-defined intra medullary lesion with blotchy calcification at the lower end of the right femoral diaphysis, possibly enchondroma or chondrosarcoma. Sections showed a cartilaginous tumor. Which of the following histological features would be most helpful to differentiate these two tumors?
- A. Focal necrosis and lobulation
- B. Tumor permeation between bone trabeculae at the periphery (Correct Answer)
- C. Extensive myxoid change
- D. High cellularity
Surveillance and Follow-up Explanation: ### Explanation
The differentiation between a low-grade **Chondrosarcoma** and an **Enchondroma** is one of the most challenging tasks in orthopedic pathology, as they often share similar cytological features.
#### 1. Why Option B is Correct
The most reliable histological hallmark of malignancy in cartilaginous tumors is **host bone entrapment (permeation)**.
* **Enchondromas** are well-circumscribed and grow by expansion, often showing a "scalloped" internal border but staying confined within their lobules.
* **Chondrosarcomas** exhibit an aggressive growth pattern where the tumor matrix infiltrates and surrounds pre-existing lamellar bone trabeculae. This "filling up" of the marrow spaces and entrapment of host bone is a definitive sign of malignancy, even in the absence of high-grade cytologic features.
#### 2. Why Other Options are Incorrect
* **Option A (Focal necrosis and lobulation):** While necrosis is more common in malignancy, focal necrosis can occasionally occur in benign lesions due to vascular compromise. Lobulation is a characteristic of almost all hyaline cartilage tumors, both benign and malignant.
* **Option C (Extensive myxoid change):** Myxoid degeneration can be seen in both tumors. While prominent in high-grade chondrosarcomas, it is not as specific a differentiator as permeation for low-grade lesions.
* **Option D (High cellularity):** Cellularity is subjective. Many enchondromas (especially in the small bones of hands/feet) can be hypercellular without being malignant.
#### 3. NEET-PG High-Yield Pearls
* **Location Rule:** A cartilaginous tumor in the small bones of the hand/feet is almost always an **Enchondroma**. In the axial skeleton (pelvis, femur, scapula), it is more likely a **Chondrosarcoma**.
* **Radiological Sign:** "Endosteal scalloping" involving more than 2/3rds of the cortical thickness suggests Chondrosarcoma.
* **Clinical Clue:** Pain in the absence of a fracture is a strong indicator of malignancy in a cartilaginous lesion.
* **Histology:** Look for **binucleated cells**; while they suggest Chondrosarcoma, permeation remains the "gold standard" for diagnosis.
More Surveillance and Follow-up Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
